Rite Aid's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Rite Aid (RAD) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Rite Aid vs Its Competitors
- TTM: Trailing 12-month revenue of 23,475M vs 1,543,897M combined for tracked competitors (1.5% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-3.8% annualized vs trailing 12 months), vs decelerating (-11.8%) for its tracked peer group.
- Growth: Rite Aid generated -4.3% revenue growth year over year in Q2 2023, vs 5.9% for its tracked competitors combined.
- Profitability: Its -17.9% net margin compares with 1.2% for the peer group.
- Peer revenue share: Rite Aid accounted for 1.6% of combined revenue among its tracked peer group, down from 1.8% a year earlier.
- Peer differentiation: Revenue per employee of $0.47M compares with $0.42M for the peer group (1.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
RAD Sales vs. its Competitors, Q2 2023
Rite Aid reported revenue contraction of 4.32 % year on year in Q2 2023, below its competitors' combined revenue growth of 5.87 %.
With a net margin of -17.88 %, Rite Aid reported lower profitability than its competitors (1.24 %).
Rite Aid generated 1.63 % of the combined sales of its peer group, down from 1.80 % a year earlier.
Rite Aid vs. its Competitors, Q2 2023
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Rite Aid and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Rite Aid Corp | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (5) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (7) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Rite Aid's competitor groups requires a Commercial License.
For context: the Pharmacy Services & Retail Drugstore industry grew revenue 6.7% year over year, combined, vs -4.3% for Rite Aid. Rite Aid's share of combined industry revenue moved from 1.47% to 1.31%, a loss of 0.15 percentage points.
Rite Aid's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Rite Aid Corp | No | No | Yes | No |
| Competitors combined (9) | ||||
| High-Confidence Competitors (5) | ||||
| Similar Growth & Profitability (8) | 25.00 % (2 of 8) | 50.00 % (4 of 8) | 50.00 % (4 of 8) | 12.50 % (1 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
RAD Stock Performance relative to its Competitors
RAD Stock Performance relative to High-Confidence Competitors
RAD Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | China Jo Jo Drugstores Holdings Inc | 282.9% | Outperformed |
| 2 | Target Corporation | 282.9% | Outperformed |
| 3 | Dollar General Corp | 282.9% | Outperformed |
| 4 | Cvs Health Corporation | 282.9% | Outperformed |
| 5 | Walgreens Boots Alliance Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Rite Aid's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Publicly Traded Peers of Rite Aid Corp
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Rite Aid Corp | 35.85 | 23,475.49 |
| Walmart Inc | 867,447.94 | 735,840.00 |
| Cvs Health Corporation | 113,062.95 | 415,086.00 |
| Target Corporation | 72,212.39 | 106,377.00 |
| Dollar General Corp | 27,548.58 | 43,637.59 |
| Walgreens Boots Alliance Inc | 10,361.50 | 154,579.00 |
| SUBTOTAL | 1,097,775.87 | 1,567,504.72 |
Sign in to see all competitors of Rite Aid Corp.
Sources: Rite Aid Corp's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Rite Aid Corp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Rite Aid's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Cvs Health Corporation | Named by the company | 85% |
| Dollar General Corp | Named by the company | 85% |
| Adtran Holdings Inc | Named by the company | 85% |
| Artificial Intelligence Technology Solutions Inc | Named by the company | 85% |
| The Cigna Group | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Rite Aid's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Rite Aid's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Rite Aid Corp | Retail Pharmacy 73.82 % |
| Walmart Inc | Walmart US 66.44 % |
| Cvs Health Corporation | Health Services 48.03 % |
| Dollar General Corp | Single Reportable Segment 100.00 % |
| Walgreens Boots Alliance Inc | United States Retail Pharmacy 78.78 % |
| Veradigm Inc | Provider 79.61 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Rite Aid's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Rite Aid Corp | 36 | 469,510 | -31,878 |
| Walmart Inc | 867,448 | 350,400 | 10,714 |
| Cvs Health Corporation | 113,063 | 1,383,620 | 16,283 |
| Target Corporation | 72,212 | 256,330 | 8,313 |
| Dollar General Corp | 27,549 | 224,936 | 8,780 |
| Walgreens Boots Alliance Inc | 10,362 | 495,446 | -25,365 |
| PEERS TOTAL | 1,097,740 | 423,556 | 6,565 |
Rite Aid's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Veradigm Inc | US 99.91 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Rite Aid's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Pharmacy Services & Retail Drugstore industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (28 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 20.14 % | 21.82 % (avg) | -1.7 pp |
| Operating Margin | -5.92 % | industry median | -3.1 pp |
| EBITDA Margin | -5.21 % | -3.58 % (avg) | -1.6 pp |
| Capital Intensity (Capex / Revenue) | 0.86 % | 1.20 % (avg) | -0.3 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Rite Aid's Valuation vs Competitive Position
Valuation multiples vs the Pharmacy Services & Retail Drugstore industry average (28 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 29.8x | - |
| EV / EBITDA | - | 15.4x | - |
| P/B | -0.1x | 3.5x | -3.6x |
| Return on Equity | 167.53 % | industry aggregate | 157.85 % |
| Return on Invested Capital | -25.93 % | 8.49 % (avg) | -34.42 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Rite Aid's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 13.17 % | 10.80 % | -9.76 % | -42.17 % | 27.13 % | 10.53 % | 2.37 % | -1.46 % |
| Operating Margin | 2.87 % | 1.46 % | 0.75 % | -3.53 % | 0.11 % | 0.50 % | -0.11 % | -3.02 % |
| Return on Invested Capital | 12.27 % | 5.26 % | 10.98 % | -8.49 % | 0.26 % | 1.17 % | -0.27 % | -9.18 % |
| P/E | 3.8x | - | 12.7x | 1.7x | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Rite Aid's Strategic Group Map
Every company in Rite Aid's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Rite Aid is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Rite Aid's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.86 % vs industry average 1.20 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Rite Aid's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Rite Aid's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Rite Aid's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Rite Aid falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Rite Aid's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Return on equity 157.9 points above the industry aggregate.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-3.8% annualized vs trailing 12 months).
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-11.8% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Rite Aid's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Rite Aid Corp | 0.03 | 0.97 | - |
| Walmart Inc | 0.10 | 0.78 | 0.38 |
| Cvs Health Corporation | 0.11 | 0.85 | 0.83 |
| Target Corporation | 0.21 | 0.96 | 1.02 |
| Dollar General Corp | 0.19 | 1.17 | 0.54 |
| Walgreens Boots Alliance Inc | 0.03 | 0.63 | 0.88 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Rite Aid's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Rite Aid Corp | Q3 2023 | -4.3 % | - |
| Walmart Inc | Q2 2026 | +5.9 % | -8.7 % |
| Cvs Health Corporation | Q2 2026 | +7.3 % | +195.7 % |
| Target Corporation | Q1 2026 | +6.7 % | -24.6 % |
| Dollar General Corp | Q2 2026 | +5.2 % | +33.8 % |
| Walgreens Boots Alliance Inc | Q2 2025 | +7.2 % | - |
| PEERS TOTAL | +6.3 % | -8.3 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Rite Aid's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Rite Aid Corp | Q3 2023 | -4.1 % | -14.6 % |
| Walmart Inc | Q2 2026 | +4.5 % | +16.7 % |
| Cvs Health Corporation | Q2 2026 | +9.0 % | +13.8 % |
| Target Corporation | Q1 2026 | +5.4 % | +31.0 % |
| Dollar General Corp | Q2 2026 | +3.3 % | +1.0 % |
| Walgreens Boots Alliance Inc | Q2 2025 | +8.7 % | -10.5 % |
Rite Aid's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Rite Aid Corp | - | - | - |
| Walmart Inc | 7.78% | 13.37% | 21.78% |
| Cvs Health Corporation | 1.92% | 2.81% | 6.39% |
| Target Corporation | 5.86% | 9.45% | 21.74% |
| Dollar General Corp | 5.38% | 4.67% | 19.56% |
| Walgreens Boots Alliance Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Rite Aid's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Rite Aid Corp | - | 0.00 |
| Walmart Inc | 39.25 | 1.18 |
| Cvs Health Corporation | 23.12 | 0.27 |
| Target Corporation | 20.93 | 0.68 |
| Dollar General Corp | 16.17 | 0.63 |
| Walgreens Boots Alliance Inc | - | 0.07 |
| PEERS AVERAGE | 49.14 | 0.70 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.